Financhill
Back

Lobe Sciences Quote, Financials, Valuation and Earnings

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Sell
16

LOBE.CX
Lobe Sciences

Last Price:
0.02
Seasonality Move:
10.27%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Lobe Sciences Price Quote

$0.02
+0.01 (+33.33%)
(Updated: November 5, 2024 at 5:55 PM ET)

Lobe Sciences Key Stats

Sell
16
Lobe Sciences (LOBE.CX) is a Sell

Day range:
$0.02 - $0.02
52-week range:
$0.01 - $0.03
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%

Volume:
5K
Avg. volume:
41.1K
1-year change:
-25%
Market cap:
$2.6M
Revenue:
$840.5K
EPS:
$-0.04

How Much Does Lobe Sciences Make?

Data Unavailable

Is Lobe Sciences Growing As A Company?

Data Unavailable

Lobe Sciences Stock Price Performance

What Is Lobe Sciences 52-Week High & Low?

Lobe Sciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Lobe Sciences?

  • How Much Debt Does Lobe Sciences Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Lobe Sciences Have?
    Cash and short term investments quarterly total is $29.5K
  • What Is Lobe Sciences’s Book Value Per Share?
    Book value per share is -0.01

Is Lobe Sciences Cash Flow Positive?

  • What Is LOBE.CX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$1.1M
  • What Is Lobe Sciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $349K
  • What Is Lobe Sciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Lobe Sciences Return On Invested Capital

Data Unavailable

Lobe Sciences Earnings Date & Stock Price

Lobe Sciences Competitors

  • Who Are Lobe Sciences's Competitors?
    Below is a list of companies who compete with Lobe Sciences or are related in some way:
    • Algernon Pharmaceuticals Inc (AGN.CX)
    • Core One Labs Inc (COOL.CX)
    • Biocure Technology Inc (CURE.CX)
    • Nova Mentis Life Science Corp (NOVA.CX)
    • Nanosphere Health Sciences Inc (NSHS.CX)

Lobe Sciences Dividend Yield

Lobe Sciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 7.15
Upside from Last Price: 47541.13%

Major Shareholders

  • How many LOBE.CX shares are owned by institutional investors?
    0 LOBE.CX shares are owned by institutional investors
  • How many LOBE.CX shares are owned by insiders?
    0 LOBE.CX shares are owned by insiders